SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,726 | -43.5% | 166,265 | +22.5% | 0.03% | -44.0% |
| Q2 2023 | $176,495 | -26.1% | 135,765 | 0.0% | 0.05% | -61.2% |
| Q1 2023 | $238,946 | -73.4% | 135,765 | -12.0% | 0.13% | -71.4% |
| Q1 2022 | $897,000 | -16.8% | 154,360 | +7.4% | 0.45% | -17.2% |
| Q4 2021 | $1,078,000 | -6.2% | 143,768 | +12.7% | 0.54% | +16.5% |
| Q3 2021 | $1,149,000 | -24.6% | 127,565 | +0.2% | 0.47% | -20.4% |
| Q2 2021 | $1,524,000 | -3.9% | 127,308 | +0.6% | 0.59% | -35.0% |
| Q1 2021 | $1,586,000 | -17.9% | 126,608 | +2.3% | 0.90% | -32.0% |
| Q4 2020 | $1,932,000 | – | 123,817 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |